학력 및 경력사항

• 이화여자대학교 의학박사
• 이화여자대학교 의과대학 졸업

• 2009-2010  | 미국 UC San Francisco 병원 감염내과 연수
• 2002-현재  | 이대목동병원 감염내과 교수
• 1999-2002  | 미국 콜로라도의대 감염내과 연구전임의
• 1997-1998  | 미국 USC 연구전임의
• 1996-1997  | 서울대병원 감염내과 전임의
• 1992-1995  | 이대동대문병원 내과 전공의 수료, 내과 전문의 취득

• 2016 | 감염병감시사업 보건복지부 장관표창장
• 2016 | MERS 방역대책 서울시장 표창장

• 2023-현재  | 대한에이즈학회 부회장
• 2023-현재  | 대한감염학회, 대한항균요법학회 감사
• 2017-2019  | 대한항균요법학회 감사
• 2015-2017  | 대한화학요법학회 총무이사
• 2014-2016  | 대한에이즈학회 보험이사
• 2013-2015  | 대한의료관련감염학회 법제이사
• 2013-2015  | 대한화학요법학회 법제이사
• 2011-현재  | Infection & Chemotherapy Editorial Board
• 2011-2023  | 대한감염학회 성인예방접종위원회 위원
• 2011-2013  | 대한화학요법학회 간행이사
• 2008-현재  | 대한 감염학회 평의원
• 2007-2009  | 대한병원감염관리학회 학술이사
• 2007-2009  | 대한화학요법학회 재정이사
• 2005-2007  | 대한화학요법학회 보험이사

•  Association between Pneumonia Development and Virulence Gene Expression in Carbapenem-Resistant Acinetobacter baumannii Development and Virulence Gene Expression in Carbapenem-Resistant Acinetobacter baumannii Isolated from Clinical Specimens.  Can J Infect Dis Med Microbiol. 2023 Dec 21;2023:8265683. 
•  The Impact of the Rapid Blood Culture Identification Panel on Antibiotic Treatment and Clinical Outcomes in Bloodstream Infections, Particularly Those Associated with Multidrug-Resistant Micro-Organisms.  Diagnostics (Basel). 2023 Nov 22;13(23):3504. doi:10.3390/diagnostics13233504. 
•  Translation of Machine Learning-Based Prediction Algorithms to Personalised Empiric Antibiotic Selection: A Population-Based Cohort Study.  Int J Antimicrob Agents. 2023 Nov;62(5):106966 . 
•  Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial.  E Clinical Medicine. 2023 Sep 7;64:102140. 
•  Study protocol for cholera vaccination as a model to measure the inflammatory response in the gut: A case of modulation with a Lactobacillus plantarum K8 lysate.  PLoS ONE. 2023, v.18 no.2 (Feb.), e0281817. 
•  Clinical and economic burden of bacteremia due to multidrug-resistant organisms in Korea: a prospective case control study.  Journal of Global Antimicrobial Resistance. 2022, v.31, 379-385. 
•  Comparison of Three Cardiovascular Risk Scores among HIV-Infected Patients in Korea: The Korea HIV/AIDS Cohort Study.  Infection and Chemotherapy. 2022, v.54 no.3, e48. 
•  Different clinical characteristics and impact of carbapenem-resistance on outcomes between Acinetobacter baumannii and Pseudomonas aeruginosa bacteraemia: a prospective observational study.  SCIENTIFIC REPORTS. 2022, v.12 no.1, 8527. 
•  Evaluation of the Efficacy of COVID-19 Booster Vaccinations in Healthcare Personnel.  VACCINES. 2022, v.10 no.11, 1797. 
•  Mortality and Causes of Death among Individuals Diagnosed with Human Immunodeficiency Virus in Korea, 2004–2018: An Analysis of a Nationwide Population-Based Claims Database.  International Journal of Environmental Research and Public Health. 2022, v.19 no.18, 11788. 
•  Rehabilitation for COVID-19 in conjunction with early awake extracorporeal membrane oxygenation support: a case report.  International Journal of Rehabilitation Research. 2022, v.45 no.3, 287-290. 
•  Risk factors for early mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteraemia.  Journal of Global Antimicrobial Resistance. 2022, v.31, 45-51. 
•  Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial.  eClinicalMedicine. 2022, v.51, 101569. 
•  Socioeconomic burden of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Korea.  Scientific Reports. 2022, v.12 no.1, 13934. 
•  Report of the Korean Society of Infectious Diseases Roundtable Discussion on Responses to the Measles Outbreaks in Korea in 2019.  Infection and Chemotherapy. 2021, v.53 no.3, 405-420. 
•  Risk of Absence of Measles Antibody in Healthcare Personnel and Efficacy of Booster Vaccination.  VACCINES. 2021, v.9 no.5, 501. 
•  Safety and immunogenicity of a seasonal quadrivalent influenza vaccine (GC3110A) in healthy participants aged ≥ 65 years.  Vaccine. 2021, v.39 no.27, 3621-3625. 
•  Validation of a questionnaire for patient awareness and the need for a community-based outpatient antimicrobial stewardship program (O-asp): A pilot study.  Antibiotics. 2021, v.10 no.4, 441. 
•  Recurrent meningococcal meningitis with complement 6 (C6) deficiency A case report .  MEDICINE. 2020, v.99 no.21, e20362. 
•  Risk factors of delayed isolation of patients with pulmonary tuberculosis.  Clinical Microbiology and Infection. 2020, v.26 no.8, 1058-1062. 
•  Survival Trend of HIV/AIDS Patients Starting Antiretroviral Therapy in South Korea between 2001 and 2015.  Yonsei medical journal. 2020, v.61 no.8, 705-711. 
•  The clinical and economic burden of communityonset complicated skin and skin structure infections in Korea.  Korean Journal of Internal Medicine. 2020, v.35 no.6, 1497-1506. 
•  Antimicrobial Stewardship Programs in Community Health Systems Perceived by Physicians and Pharmacists: A Qualitative Study with Gap Analysis.  ANTIBIOTICS-BASEL. 2019, v.8 no.4, 252. 
•  Clinical and Molecular Characterization of Panton-Valentine Leukocidin-Positive Invasive Staphylococcus aureus Infections in Korea.  MICROBIAL DRUG RESISTANCE. 2019, v.25 no.3, 450-456. 
•  Epidemiological characteristics of HIV infected Korean: Korea HIV/AIDS Cohort Study.  Epidemiology and health. 2019, v.41, e2019037. 
•  How Can We Identify the Suspicious Pulmonary Tuberculosis Patients to Prevent Nosocomial Transmission?.  Journal of Korean Medical Science. 2019, v.34 no.43, 1~2. 
•  Immunogenicity and safety of a new live attenuated herpes zoster vaccine (NBP608) compared to Zostavax (R) in healthy adults aged 50 years and older.  VACCINE. 2019, v.37 no.27, 3605-3610. 
•  Impact of antimicrobial treatment duration on outcome of Staphylococcus aureus bacteraemia: a cohort study.  CLINICAL MICROBIOLOGY AND INFECTION. 2019, v.25 no.6, 723-732. 
•  Impact of participation in a surgical site infection surveillance network: results from a large international cohort study.  J Hosp Infect. 2019, v.102 no.3, 267-276. 
•  Impact of a change in duration of prophylactic antibiotics on infectious complications after radical cystectomy with a neobladder..  Medicine (Baltimore). 2018-11. 
•  Clinical and Molecular Characterization of Panton-Valentine Leukocidin-Positive Invasive Staphylococcus aureus Infections in Korea..  Microb Drug Resist. 2018-10. 
•  Impact of antimicrobial treatment duration on outcome of Staphylococcus aureus bacteraemia: a cohort study..  Clin Microbiol Infect.. 2018-10. 
•  Factors Influencing Vaccination in Korea: Findings From Focus Group .  J Prev Med Public Health. 2018-07. 
•  Predictors of mortality in Middle East respiratory syndrome (MERS).  Thorax. 2018-03. 
•  The Prevalence and Risk Factors of Renal Insufficiency among Korean HIV-Infected Patients: The Korea HIV/AIDS Cohort Study.  Infect Chemother. 2017-09. 
•  Validation of the Korean National Healthcare-associated Infections Surveillance System (KONIS): an intensive care unit module report.  J Hosp Infect. 2017-08. 
•  Safety and immunogenicity of influenza vaccine among HIV-infected adults: Conventional vaccine vs. intradermal vaccine.  Hum Vaccin Immunother. 2016-12. 
•  Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity.  Clin Microbiol Infect. 2016-10. 
•  Five-year decreased incidence of surgical site infections following gastrectomy and prosthetic joint replacement surgery through active surveillance by the Korean Nosocomial Infection Surveillance System.  J Hosp Infect. 2016-08. 
•  Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis.  BMC Infect Dis. 2016-07. 
•  Trends in the distribution and antimicrobial susceptibility of causative pathogens of device-associated infection in Korean intensive care units from 2006 to 2013: results from the Korean Nosocomial Infections Surveillance System (KONIS).  J Hosp Infect. 2016-04. 

• [의사신문] “날로 증가하는 원내감염···예방·관리에 관심 필요” 2021-09-01
• [헬스조선] "코로나19만 걱정? 병원 내 감염병도 증가합니다" 2021-06-28
• [메디컬월드뉴스] 의료기관 종사자에게 예방접종을 하는 이유와 필요한 백신은? 2019-10-24